Biobran MGN-3

arabinoxylan from rice bran · Daiwa Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Biobran MGN-3, covering 2009-11-23 to 2016-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV [Phase 2]